Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese Participants
Status:
Completed
Trial end date:
2019-07-11
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacokinetics, safety and tolerability of a single oral dose
of baloxavir marboxil (40 mg or 80 mg) in healthy Chinese participants.